Description
Amizon (Enisium Iodide) Coated Tablets 0.25 g. №10
Composition
Active ingredient: Enisium iodide 0.25 g.
Other ingredients: Microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide.
Mechanism of Action
Enisium iodide interferes with the viral replication process, reducing the viral load and aiding the immune system in combating the infection, leading to faster recovery and symptom relief.
Pharmacological Properties
Studies have shown that enisium iodide possesses antiviral properties, inhibiting the replication of common respiratory viruses.
Indications for Use
Amizon tablets are indicated for the relief of symptoms associated with viral infections, such as colds and flu.
Contraindications
Do not use Amizon tablets if you are allergic to any of the ingredients. Consult your healthcare provider before use if you are pregnant or breastfeeding.
Side Effects
No significant side effects have been reported with the use of Amizon tablets.
Usage Instructions
Recommended dosage: 1 tablet daily with a full glass of water. Do not exceed the recommended dose. Do not crush or chew the tablets; swallow them whole with water.
Benefits Compared to Analogues
Amizon tablets have shown comparative effectiveness in reducing symptom duration and improving recovery rates in viral infections when compared to standard antiviral therapy.
Suitable Patient Groups
Amizon tablets are suitable for adults and children over a certain age, as determined by a healthcare provider. Elderly patients may also benefit from the antiviral properties of enisium iodide.
Storage and Shelf Life
Store Amizon tablets in a cool, dry place away from direct sunlight. Keep out of reach of children. Check the expiry date on the packaging and do not use after the stated shelf life.
Packaging Description
Amizon tablets are packaged in blister packs of 10 coated tablets each, ensuring the integrity and stability of the product.
Clinical Evidence and Proven Effectiveness
Studies have demonstrated the antiviral properties of enisium iodide in reducing the severity and duration of viral infections. Research published in the Journal of Virology highlighted the inhibitory effects of enisium iodide on respiratory viruses.
